PET Scans Show Metabolic Changes that Herald Future Memory Losses

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


During the past few years, researchers have searched fervently for ways to identify people at risk for Alzheimer's disease before these individuals develop any symptoms. Several groups have detected structural changes in the brain that appear to precede the disease's clinical onset, often marked by memory impairment. And now Mony J. de Leon of the New York University School of Medicine and colleagues report in today's issue of the Proceedings of the National Academy of Sciences that they have discovered metabolic changes in the brains of healthy men and women that can also predict impending memory problems.

The scientists studied 48 subjects between 60 and 80 years old, all of whom initially scored within the normal range on tests used to detect early memory loss. PET scans revealed that 12 of these subjects showed reduced glucose metabolism in a brain region called the entorhinal cortex. When de Leon and crew reevaluated these same 12 people three years later, they found that 11 had experienced mild cognitive impairment (MCI), a condition that often leads to Alzheimer's, and one had developed Alzheimer's disease. Also among this group, carriers of the apolipoprotein E4 gene¿a marker linked to Alzheimer's¿showed dramatic drops in brain metabolic activity. The remaining subjects with normal PET scans suffered no mental decline during the course of the study.

"Our work extends the use of PET scanning to identifying in normal aging subjects the earliest metabolic abnormalities that may lead to the memory losses referred to as MCI," de Leon says. "The results will allow us to distinguish individuals at increased risk of memory impairment, but it is still too early to apply the brain scans outside of a research setting. We need to confirm our results with a larger group of subjects and to identify the biological and physiological factors leading to the metabolism losses. If we can identify these factors, then we may be able to find a way to delay the onset of Alzheimer's or prevent it altogether."

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe